Welcome to the Weekly Roll Up, Heady Vermont’s regular review of the top cannabis news locally, from our region and beyond.
Heady Vermont reporter Tim Branfalt takes a deep dive on the shortcomings of roadside saliva testing for drug impairment, including cannabis.
Meanwhile, VTDigger reporters that a second House committee is taking testimony on legislation that calls for the implementation of such a regime as part of the public safety response to marijuana legalization.
Heady Vermont co-founder, Eli Harrington, weighs in on the state’s transfer of $300,000 out of the medical marijuana registry fund, asking policymakers to spell out how the program fulfills its mission without shelling out much dough?
Harrington argues that, if the program is bringing in extra money, it should be used to make medical cannabis more affordable for low-income patients.
On that topic, medical marijuana patient Vanessa Thomas, discussed with Heady Vermont her own challenges paying for medicine that she says changed her life.
“If we could get medical cannabis through Medicaid that would be so great, people would actually be able to afford it,” Thomas